Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 109 citing articles:

Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Qianqian Zhang, Rong Xiang, Shanshan Huo, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 304
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 219
Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events
Junxian Ou, Wendong Lan, Xiaowei Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 189
In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2
Agnieszka M. Szemiel, Andres Merits, Richard Orton, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009929-e1009929
Open Access | Times Cited: 140
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 80
Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants
Clauber Henrique Souza da Costa, Camila Auad Beltrão de Freitas, Cláudio Nahum Alves, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 78
Immune evasion and ACE2 binding affinity contribute to SARS-CoV-2 evolution
Wentai Ma, Haoyi Fu, Fanchong Jian, et al.
Nature Ecology & Evolution (2023) Vol. 7, Iss. 9, pp. 1457-1466
Open Access | Times Cited: 54
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York
Anthony P. West, Joel O. Wertheim, Jade Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 73
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
Nerea Zabaleta, Wenlong Dai, Urja Bhatt, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 9, pp. 1437-1453.e8
Open Access | Times Cited: 71
Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo
Zhaoyong Zhang, Eric Zeng, Lu Zhang, et al.
Cell Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 60
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, et al.
International Journal of Biological Macromolecules (2022) Vol. 219, pp. 980-997
Open Access | Times Cited: 56
Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants
Vanessa Monteil, Brett Eaton, Elena Postnikova, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 8
Open Access | Times Cited: 46
SARS-CoV-2 E484K Mutation Narrative Review: Epidemiology, Immune Escape, Clinical Implications, and Future Considerations
Wanting Yang, Wei-Hsuan Huang, Tsai‐Ling Liao, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 373-385
Open Access | Times Cited: 44
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
Ryuta Uraki, Shun Iida, Peter Halfmann, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
The molecular basis for SARS-CoV-2 binding to dog ACE2
Zengyuan Zhang, Yanfang Zhang, Kefang Liu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 52
The SARS-CoV-2 spike protein is vulnerable to moderate electric fields
Claudia R. Arbeitman, Pablo A. Rojas, Pedro Ojeda-May, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 43
Rampant C-to-U deamination accounts for the intrinsically high mutation rate in SARS-CoV-2 spike gene
Xueyan Liu, Xuan Liu, Jie Zhou, et al.
RNA (2022) Vol. 28, Iss. 7, pp. 917-926
Open Access | Times Cited: 35
Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants
Zhen Yang, Shuo Zhang, Yuping Tang, et al.
Aging and Disease (2022) Vol. 13, Iss. 2, pp. 402-402
Open Access | Times Cited: 35
Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID‐19 and response to treatment
Richard Head, Eugenie R. Lumbers, Bevyn Jarrott, et al.
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 34
Point-of-care testing of infectious diseases: recent advances
Mei-Yun Shang, Jiuchuan Guo, Jinhong Guo
Sensors & Diagnostics (2023) Vol. 2, Iss. 5, pp. 1123-1144
Open Access | Times Cited: 16
COVID-19 Variants and Vaccine Development
Ziyao Zhao, Sahra Bashiri, Zyta M. Ziora, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 757-757
Open Access | Times Cited: 6
Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations
Jobin John Jacob, Karthick Vasudevan, Agila Kumari Pragasam, et al.
mBio (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top